Xu Xialian, Hu Jiachang, Song Nana, Chen Rongyi, Zhang Ting, Ding Xiaoqiang
Department of Nephrology, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China.
Shanghai Institute of Kidney Disease and Dialysis, No.180 Fenglin Road, Shanghai, 200032, People's Republic of China.
BMC Nephrol. 2017 Jan 17;18(1):27. doi: 10.1186/s12882-016-0433-1.
Mounting evidence indicated that the elevated serum uric acid level was associated with an increased risk of acute kidney injury (AKI). Our goal was to systematically evaluate the correlation of serum uric acid (SUA) level and incidence of AKI by longitudinal cohort studies.
We searched electronic databases and the reference lists of relevant articles. 18 cohort studies with 75,200 patients were analyzed in this random-effect meta-analysis. Hyperuricemia was defined as SUA levels greater than 360-420 μmol/L (6-7 mg/dl), which was various according to different studies. Data including serum uric acid, serum creatinine, and incidence of AKI and hospital mortality were summarized using random-effects meta-analysis.
The hyperuricemia group significantly exerted a higher risk of AKI compared to the controls (odds ratio OR 2.24, 95% CI 1.76-2.86, p < 0.01). Furthermore, there is less difference of the pooled rate of AKI after cardiac surgery between hyperuricemia and control group (34.3% vs 29.7%, OR 1.24, 95% CI 0.96-1.60, p = 0.10), while the rates after PCI were much higher in hyperuricemia group than that in control group (16.0% vs 5.3%, OR 3.24, 95% CI 1.93-5.45, p < 0.01). In addition, there were significant differences in baseline renal function at admission between hyperuricemia and control groups in most of the included studies. The relationship between hyperuricemia and hospital mortality was not significant. The pooled pre-operative SUA levels were higher in AKI group than that in the non-AKI group.
Elevated SUA level showed an increased risk for AKI in patients and measurements of SUA may help identify risks for AKI in these patients.
越来越多的证据表明,血清尿酸水平升高与急性肾损伤(AKI)风险增加相关。我们的目标是通过纵向队列研究系统评估血清尿酸(SUA)水平与AKI发病率的相关性。
我们检索了电子数据库及相关文章的参考文献列表。本随机效应荟萃分析纳入了18项队列研究,共75200例患者。高尿酸血症定义为SUA水平大于360 - 420μmol/L(6 - 7mg/dl),不同研究的定义有所不同。采用随机效应荟萃分析总结血清尿酸、血清肌酐、AKI发病率及医院死亡率等数据。
与对照组相比,高尿酸血症组发生AKI的风险显著更高(优势比OR 2.24,95%置信区间1.76 - 2.86,p < 0.01)。此外,高尿酸血症组与对照组心脏手术后AKI的合并发生率差异较小(34.3%对29.7%,OR 1.24,95%置信区间0.96 - 1.60,p = 0.10),而高尿酸血症组PCI术后的发生率远高于对照组(16.0%对5.3%,OR 3.24,95%置信区间1.93 - 5.45,p < 0.01)。此外,在大多数纳入研究中,高尿酸血症组与对照组入院时的基线肾功能存在显著差异。高尿酸血症与医院死亡率之间的关系不显著。AKI组术前SUA的合并水平高于非AKI组。
SUA水平升高表明患者发生AKI的风险增加,检测SUA可能有助于识别这些患者发生AKI的风险。